Cooperative Agreement FA86502526L16
Award Date
4/29/25
Completion Date
4/29/25
Dollars Obligated
$466K
Funding Federal Agency
Air Force
Awarding Federal Agency
Air Force Research Laboratory
Federal Grant Program
12.800
Assistance Type
Cooperative Agreement
Place of Performance
United States
Similar Awards
The University of Maryland, Baltimore (UMB) was awarded a $1,500,000 Cooperative Agreement from the U.S. Air Force under the Air Force Defense Research Sciences Program (CFDA 12.800) on March 18, 2025. The purpose of this award is to develop "TRIAGE CLINICAL DECISION SUPPORT FOR PROLONGED FIELD CARE SCENARIOS." As a major academic research institution, UMB will leverage its expertise in biomedical research, clinical trials, and healthcare services to deliver innovative products and...
This Cooperative Agreement award from the Department of the Air Force's Defense Research Sciences Program (CFDA 12.800) provides $167,000.00 to the University of Maryland, Baltimore (UMB) to study the "Effects of Long-Range Aeromedical Evacuation on Military Relevant Complex Injuries". The performance period for this award is from July 26, 2023 to October 26, 2024. UMB, as the prime awardee, will leverage its expertise and facilities in medical and biomedical research to conduct this...
The University of Maryland, Baltimore received a $501,000 Cooperative Agreement award from the Department of the Air Force Materiel Command Research Laboratory under the Air Force Defense Research Sciences Program (CFDA 12.800). The award is titled "DEFEROXAMINE AS A RESUSCITATIVE ADJUVANT TO MITIGATE DAMAGE CAUSED BY COMBINED TRAUMATIC BRAIN INJURY" and has a performance period from March 3, 2025 to March 3, 2028. The project aims to investigate the use of deferoxamine, a...
This Cooperative Agreement award from the Air Force Defense Research Sciences Program (CFDA 12.800) provides $479,000.00 in funding to the University of Maryland, Baltimore to conduct research on "MEASURING DYSAUTONOMIA FOR THE RAPID DETERMINATION AND PROGRESSION OF TBI" over a period of 3 years from March 14, 2025 to March 14, 2028. The research aims to develop new methods for rapidly diagnosing and monitoring the progression of traumatic brain injuries by measuring dysautonomia,...
This Cooperative Agreement award from the U.S. Air Force under CFDA 12.800 - Air Force Defense Research Sciences Program provides $730,466.18 in funding to the University of Maryland, Baltimore (UMB) for the "AUSTERE ECMO VALIDATION" project. The award period runs from February 2, 2024 to February 2, 2026. The project is focused on conducting research and validation activities related to extracorporeal membrane oxygenation (ECMO) technology in austere environments. UMB, a major...
This federal Cooperative Agreement award from the Department of the Air Force under the Air Force Defense Research Sciences Program (CFDA 12.800) provides $275,000.00 in funding to the University of Maryland, Baltimore (UMB) to conduct a "Study of the Delay of Oxygenation from the Lung to the Finger Using a Rapid and Automated Protocol." The award period is from July 10, 2024 to January 9, 2026. The Air Force Defense Research Sciences Program supports fundamental and applied scientific...
The University of Maryland, College Park has been awarded a $161,276 Project Grant by the Air Force Research Laboratory under the Air Force Defense Research Sciences Program (CFDA 12.800). The award, with a performance period from August 15, 2024 to August 14, 2027, will support research on "Decoding Imagined Speech". The University of Maryland is a prominent research-intensive institution that has a broad portfolio of federal research contracts and grants, including work with the...
The University of Maryland, College Park was awarded a $280,000 Project Grant from the Department of the Air Force Materiel Command Research Laboratory under the Air Force Defense Research Sciences Program (CFDA 12.800) to conduct research on multiscale characterization of collective astrocyte dynamics from August 1, 2021 through July 31, 2023. As part of the Air Force Defense Research Sciences Program, which aims to maintain Air Force technological superiority through basic and applied...
The University of Maryland, Baltimore (UMB) was awarded a $299,900 Project Grant from the Department of the Navy's Office of Naval Research under the Basic and Applied Scientific Research (CFDA 12.300) program. The grant supports a research project titled "ANTI-INFLAMMATORY ACTIONS OF HYPEROXIA" with a performance period from August 1, 2024 to July 31, 2025. As a leading academic health and biomedical research institution, UMB will conduct fundamental and applied research on the...
This federal Project Grant award of $249,999.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is supporting research conducted by the University of Maryland, Baltimore (UMB) to gain insights into multiple sclerosis pathology. The research project will leverage 7-T MRI and multiomics analysis of serologic samples to advance the understanding of this neurological disorder. The award period runs from August 15, 2024 to August 14,...